DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 59 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,962,488 | -7.3% | 232,900 | +2.6% | 0.02% | -14.8% |
| Q2 2023 | $3,195,498 | -16.3% | 226,953 | -8.2% | 0.03% | -27.0% |
| Q1 2023 | $3,819,827 | +20.3% | 247,238 | +27.6% | 0.04% | +42.3% |
| Q4 2022 | $3,175,825 | +0.3% | 193,766 | +13.2% | 0.03% | -3.7% |
| Q3 2022 | $3,167,000 | +2084.1% | 171,137 | +1048.6% | 0.03% | +2600.0% |
| Q4 2021 | $145,000 | -95.5% | 14,900 | -84.3% | 0.00% | -97.0% |
| Q3 2021 | $3,223,000 | +128.7% | 94,840 | +146.5% | 0.03% | +120.0% |
| Q2 2021 | $1,409,000 | +16.0% | 38,471 | +42.0% | 0.02% | 0.0% |
| Q1 2021 | $1,215,000 | -33.1% | 27,096 | -14.9% | 0.02% | -37.5% |
| Q4 2020 | $1,817,000 | +7.7% | 31,823 | -3.3% | 0.02% | -25.0% |
| Q3 2020 | $1,687,000 | -31.6% | 32,900 | -20.4% | 0.03% | -3.0% |
| Q2 2020 | $2,468,000 | +35.0% | 41,318 | +40.7% | 0.03% | -26.7% |
| Q4 2019 | $1,828,000 | +202.6% | 29,371 | -2.6% | 0.04% | 0.0% |
| Q1 2018 | $604,000 | +77.6% | 30,146 | +101.0% | 0.04% | +60.7% |
| Q4 2017 | $340,000 | -64.2% | 15,000 | -70.0% | 0.03% | -67.8% |
| Q3 2017 | $950,000 | – | 50,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |